Learn the story of how Medtronic, one of the world's largest medical equipment and therapies suppliers, generates money and ...

The Reveal LINQ monitor developed by Medtronic identifies more people who have atrial fibrillation after a cryptogenic stroke (CS) – with no identified cause – or transient ischaemic attack (TIA).

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease ... Both the RC and PC ...

The US Food and Drug Administration (FDA) has issued a Class I recall for Medtronic’s NIM Vital Nerve Monitoring System due ...

New pacing systems have recently been specifically designed by the major companies for safe use in the MRI environment (EnRhythm, Advisa, and Revo MRI SureScan pacemakers and CapSureFix MRI leads ...

Medtronic disclosed that the Food and Drug Administration approved Simplera, the medical technology company's continuous glucose monitor. The Dublin-based company said its Simplera platform ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Ajizian, Medtronic’s chief medical officer of acute care and monitoring, revealed his departure on LinkedIn Thursday. The executive worked in the patient monitoring business before Medtronic ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...